InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Fleming Alison B, Chief Technology Officer. Director active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 2 filings have been recorded. History available since 10 August 2021. The latest transaction was filed on 10 August 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
1,386 shares@ US$19.0350.0% of flowCommon StockSEC:0001192482-21-000662
1,386 shares@ US$19.030.0015% mcap50.0% of flowCommon StockSEC:0001192482-21-000662:0
2 of 2 declarations
About Fleming Alison B
Alison B. Fleming is the EVP and Chief Technical Officer at Collegium Pharmaceutical, Inc. She oversees technical development and innovation within the company. Her expertise is essential for research and development of new products.
